Interpace Biosciences
IDXG
#11365
Rank
N/A
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Interpace Biosciences (IDXG)

Earnings in 2026 (TTM): NZ$6.99 Million

According to Interpace Biosciences's latest financial reports the company's current earnings are NZ$36.14 Million. In 2025 the company made an earning of NZ$6.91 Million a decrease over its 2024 earnings that were of NZ$15.12 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Interpace Biosciences from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$6.99 M1.19%
2025 NZ$6.91 M-54.26%
2024 NZ$15.12 M303.23%
2023 NZ$3.75 M-144.63%
2022 -NZ$8.41 Million-60.98%
2021 -NZ$21.54 Million-52.04%
2020 -NZ$44.9 Million-2.68%
2019 -NZ$46.14 Million121.84%
2018 -NZ$20.8 Million-6.07%
2017 -NZ$22.15 Million96.31%
2016 -NZ$11.28 Million-86.7%
2015 -NZ$84.83 Million382.48%
2014 -NZ$17.59 Million134.35%
2013 -NZ$7.51 Million323.89%
2012 -NZ$1.77 Million-79.01%
2011 -NZ$8.44 Million29.08%
2010 -NZ$6.54 Million-82.57%
2009 -NZ$37.48 Million-39.28%
2008 -NZ$61.73 Million146.45%
2007 -NZ$25.05 Million-269.18%
2006 NZ$14.8 M-131.08%
2005 -NZ$47.63 Million-177.16%
2004 NZ$61.72 M78.33%
2003 NZ$34.61 M-142.02%
2002 -NZ$82.37 Million-469.63%
2001 NZ$22.28 M-68.92%
2000 NZ$71.69 M140.45%
1999 NZ$29.81 M
1997 NZ$4.2 M